从瘀热互结论治经皮冠状动脉介入治疗术后再狭窄炎性反应

Discussion on an in-stent restenosis caused by inflammation after PCI based on blood and heat stasis

近年来研究趋向于认为炎性反应主导了经皮冠状动脉介入治疗(PCI)术后再狭窄的病理过程,而目前并没有针对炎性反应的推荐用药。中医药在这方面有潜在优势,通过对PCI术后中医病因病机分析发现瘀热互结证与PCI术后炎性反应存在有机对应关系。文章分析PCI术后病因病机特点,结合临床经验,介绍从瘀热互结入手,针对炎性反应的PCI术后再狭窄防治。

In recent years, more and more researches had been verified that inflammation played the main role in the pathological process of in-stent restenosis after percutaneous coronary intervention（PCI）. However, there was no recommended medicine to treat cardiovascular inflammation but TCM might have methods. By the analysis of the etiology and pathogenesis of in-stent restenosis after PCI, we found an inner connection between inflammation and the syndrome of blood and heat stasis. This article made an introduction of the analysis of the etiology and pathogenesis in stent restenosis after PCI. In addition, based on clinical experience, the prevention and treatment inflammation for in-stent restenosis after PCI were introduced from the syndrome of blood and heat stasis.